Aqueous and organic solvent-extracts of selected South African medicinal plants possess antimicrobial activity against drug-resistant strains of Helicobacter pylori: Inhibitory and bactericidal potential

International Journal of Molecular Sciences

Volumn 12, Issue 9, 2011, Pages 5652-5665

  Njume, Collise ^a   Jide, Afolayan A ^a   Ndip, Roland N ^a,b  

^a UNIVERSITY OF FORT HARE   (South Africa)

^b UNIVERSITY OF BUEA   (Cameroon)

Author keywords

Antimicrobial activity; Drug discovery; Helicobacter pylori; Medicinal plants

Indexed keywords

ACETONE; ALCOHOL; ALEPIDEA AMATYMBICA EXTRACT; AMOXICILLIN; ANTIINFECTIVE AGENT; COMBRETUM MOLLE EXTRACT; GARCINIA KOLA EXTRACT; METRONIDAZOLE; ORGANIC SOLVENT; PLANT EXTRACT; SCLEROCARYA BIRREA EXTRACT; STRYCHNOS EXTRACT; UNCLASSIFIED DRUG; WATER; SOLVENT;

ALEPIDEA AMATYMBICA; ANTIBIOTIC RESISTANCE; AQUEOUS SOLUTION; ARTICLE; BACTERIAL GROWTH; BACTERICIDAL ACTIVITY; BACTERIUM ISOLATION; COMBRETUM MOLLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG SYNTHESIS; GROWTH INHIBITION; HELICOBACTER PYLORI; MEDICINAL PLANT; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; SCLEROCARYA BIRREA; SOUTH AFRICA; STRYCHNOS; CHEMISTRY; CLASSIFICATION; DOSE RESPONSE; DRUG EFFECTS; MICROBIAL SENSITIVITY TEST; PROCEDURES; SPECIES DIFFERENCE;

ALEPIDEA AMATYMBICA; COMBRETUM MOLLE; GARCINIA KOLA; HELICOBACTER PYLORI; SCLEROCARYA BIRREA; STRYCHNOS;

ACETONE; AMOXICILLIN; ANTI-BACTERIAL AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, BACTERIAL; ETHANOL; HELICOBACTER PYLORI; METRONIDAZOLE; MICROBIAL SENSITIVITY TESTS; PLANT EXTRACTS; PLANTS, MEDICINAL; SOLVENTS; SOUTH AFRICA; SPECIES SPECIFICITY; WATER;

EID: 80053184607     PISSN: None     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms12095652     Document Type: Article

References (38)

1. Ndip, R.N.; Malange, T.A.E.; Ojongokpoko, J.E.A.; Luma, H.N.; Malongue, A.; Akoachere, J.F.K.; Ndip, L.M.; MacMillan, M.; Weaver, L.T. Helicobacter pylori isolates recovered from gastric biopsies of patients with gastro-duodenal pathologies in Cameroon: Current status of antibiogram. Trop. Med. Int. Health 2008, 13, 848-854.
2. Atherton, J.C. The pathogenesis of Helicobacter pylori-induced gastro-duodenal diseases. Annu. Rev. Pathol. 2006, 1, 63-96.
3. Adeniyi, C.B.A.; Temitope, O.L.; Gail, B.M. In vitro susceptibility of Helicobacter pylori to extracts of Eucalyptus camaldulensis and Eucalyptus torelliana. Pharm. Biol. 2009, 47, 99-102.
4. Mégraud, F.; Lehours, P. Helicobacter pylori detection and antimicrobial susceptibility testing. Clin. Microbiol. Rev. 2007, 20, 280-283.
5. Boyanova, L. Prevalence of multidrug-resistant Helicobacter pylori in Bulgaria. J. Med. Microbiol. 2009, 58, 930-935.
6. Njume, C.; Afolayan, A.J.; Ndip, R.N. An overview of antimicrobial resistance and the future of medicinal plants in the treatment of Helicobacter pylori infections. Afr. J. Pharm. Pharmacol. 2009, 3, 685-699.
7. Perna, F.; Zullo, A.; Ricci, C.; Hassan, C.; Morini, S.; Vaira, D. Levofloxacin-based triple therapy for Helicobacter pylori re-treatment: Role of bacterial resistance. Dig. Liver Dis. 2007, 39, 1001-1005.
8. Abbas, Z.; Yacoob, J.; Abid, S.; Jafri, W.; Islam, M.; Azam, Z.; Hilal, I. Furazolidone, co-amoxiclav, colloidal bismuth subcitrate and esomeprazole for patients who failed to eradicate Helicobacter pylori with triple therapy. Dig. Dis. Sci. 2009, 54, 1953-1957.
9. Boyanova, L.; Mitov, I. Geographic map and evolution of primary Helicobacter pylori resistance to antimicrobial agents. Expert Rev. Anti Infect. Ther. 2010, 8, 59-70.
10. Malfertheiner, P.; Megraud, F.; O'Morain, C.; Bazzoli, F.; El-Omar, E.; Graham, D.; Hunt, R.; Rokkas, T.; Vakil, N.; Kuipers, E.J. Current concepts in the management of Helicobacter pylori infection: The Maastricht III Consensus Report. Gut 2007, 56, 772-781.
11. Eisig, J.N.; Silva, F.M.; Barbuti, R.C.; Rodriguez, C.N.; Malfertheiner, P.; Filho, M.J.P.P.; Zaterka, S. Efficacy of a 7-day course of furazolidone, levofloxacin, and lansoprazole after failed Helicobacter pylori eradication. BMC Gastroenterol. 2009, 9. doi:10.1186/1471-230X-9-38.
12. Afolayan, A.J.; Lewu, F.B. Antimicrobial activity of Alepidea amatymbica. Pharm. Biol. 2009, 47, 436-439.
13. Ndip, R.N.; Malange, T.A.E.; Mbulla, S.M.; Luma, H.N.; Agnes, M.; Ndip, L.M.; Nyongbela, K.; Wirmum, C.; Efange, S.M.N. In vitro anti-Helicobacter pylori activity of extracts of selected medicinal plants from North West Cameroon. J. Ethnophamacol. 2007, 114, 452-457.
14. Ndip, R.N.; Ajonglefac, A.N.; Mbullah, S.M.; Tanih, N.F.; Akoachere, J.F.K.; Ndip, L.M.; Luma, H.N.; Wirmum, C.; Ngwa, F.; Efange, S.M.N. In vitro anti-Helicobacter pylori activity of Lycopodium cernuum (Linn) Pic. Serm. Afr. J. Biotechnol. 2008, 7, 3989-3994.
15. Njume, C.; Afolayan, A.J.; Ndip, R.N. Preliminary phytochemical screening and in vitro anti-Helicobacter pylori activity of acetone and aqueous extracts of the stem bark of Sclerocarya birrea (Anacardiaceae). Arch. Med. Res. 2011, 42, 252-257.
16. Dold, A.P.; Cocks, M.L. The trade in medicinal plants in the Eastern Cape Province, South Africa. S. Afr. J. Sci. 2002, 98, 589-597.
17. Philippe, G.; Angenot, L.; Tits, M.; Frederich, M. About the toxicity of some Strychnos species and their alkaloids. Toxicon 2004, 44, 405-416.
18. Eloff, J.N. Antibacterial activity of Murula (Sclerocarya birrea (A. rich.) Hochst. Subsp. Caffra (Sond.) Kokwaro) (Anacardiaceae) bark and leaves. J. Ethnopharmacol. 2001, 76, 305-308.
19. Eloff, J.N.; Famakin, J.O.; Katerere, D.R.P. Combretum woodii (Combretaceae) leaf extracts have high activity against gram-negative and gram-positive bacteria. Afr. J. Biotechnol. 2005, 4, 1161-1166.
20. Akinpelu, D.A.; Adegboye M.F.; Adeloye, O.A.; Okoh, A.I. Biocidal activity of partially purified fractions from methanolic extract of Garcinia kola (Heckel) seeds on bacterial isolates. Biol. Res. 2008, 41, 277-287.
21. Masoko, P.; Mmushi, T.J.; Mogashoa, M.M.; Mokgotho, M.P.; Mampuru, L.J.; Howard, R.L. In vitro evaluation of the antifungal activity of Sclerocarya birrea extracts against pathogenic yeasts. Afr. J. Biotechnol. 2008, 7, 3521-3526.
22. Ezekiel, C.N.; Anokwuru, C.P.; Nsofor, E.; Odusanya, O.A.; Adebanjo, O. Antimicrobial activity of the methanolic and crude alkaloid extracts of Acalypha wilkesiana cv. macafeeana copper leaf. Res. J. Microbiol. 2009, 4, 269-277.
23. Eloff, J.N. Which extractant should be used for the screening and isolation of antimicrobial components from plants? J. Ethnopharmacol. 1998, 60, 1-8.
24. Castillo-juárez, I.; González, V.; Aime-aguilar, H.; Martínez, G.; Linares, E.; Bye, R.; Romero, I. Anti-Helicobacter pylori activity of plants used in Mexican traditional medicine for gastrointestinal disorders. J. Ethnopharmacol. 2009, 122, 402-405.
25. Tanih, N.F.; Okeleye, B.I.; Naido, N.; Clarke, A.M.; Mkweshana, N.; Green, E.; Ndip, L.M.; Ndip, R.N. Marked susceptibility of South African Helicobacter pylori strains to ciprofloxacin and amoxicillin: Clinical implication. S. Afr. Med. J. 2010, 100, 49-52.
26. Ahmad, N.; Zakaria, W.R.; Mohamed, R. Analysis of antibiotic susceptible patterns of Helicobacter pylori isolates from Malaysia. Helicobacter 2011, 16, 47-51.
27. Smith, S.I.; Oyedeji, K.S.; Arigbabu, A.O.; Atimomo, C.; Coker, A.O. High amoxicillin resistance in Helicobacter pylori isolated from gastritis and peptic ulcer patients in Western Nigeria. J. Gastroenterol. 2001, 36, 67-68.
28. Wong, B.C.; Wang, W.H.; Berg, D.E.; Fung, F.M.; Wong, K.W.; Wong, W.M.; Lai, K.C.; Cho, C.H.; Hui, W.M.; Lam, S.K. High prevalence of mixed infections by Helicobacter pylori in Hong Kong: Metronidazole sensitivity and overall genotype. Aliment. Pharmacol. Ther. 2001, 15, 493-503.
29. Kim, J.J.; Kim, J.G.; Kwon, D.H. Mixed infection of antibiotic susceptible and resistant Helicobacter pylori isolates in a single patient and underestimation of antimicrobial susceptibility testing. Helicobacter 2003, 8, 202-206.
30. Ayala, G.; Galvan-Portillo, M.; Chihu, L.; Fierros, G.; Sanchez, A.; Carrillo, B.; Roman, A.; Lopez-Carrillo, L.; Silva-Sanchez, J.; Studygroup. Resistance to antibiotics and characterization of Helicobacter pylori strains isolated from antrum and body from adults in Mexico. Microb. Drug Resist. 2011, 17, 149-155.
31. Akinpelu, D.A.; Aiyegoro, A.O.; Okoh, A.I. Studies on the biocidal and cell membrane disruption potentials of stem bark extracts of Afzelia africana (Smith). Biol. Res. 2009, 42, 339-349.
32. Madamombe, I.T.; Afolayan, A.J. Evaluation of antimicrobial activity of extracts from South African Usnea barbata. Pharm. Biol. 2003, 41, 199-202.
33. Moghaddam, M.N.; Karamoddin, M.K.; Ramezani, M. In vitro antibacterial activity of Sweet Basil fractions against Helicobacter pylori. J. Biol. Sci. 2009, 9, 276-279.
34. Eloff, J.N.; Katerere, D.R.; McGaw, L.J. The biological activity and chemistry of the southern African Combretaceae. J. Ethnopharmacol. 2008, 119, 686-699.
35. Cowan, M.M. Plant products as antimicrobial agents. Clin. Microbiol. Rev. 1999, 12, 564-582.
36. Adeboye, M.F.; Akinpelu, D.A.; Okoh, A.I. The bioactive and phytochemical properties of Garcinia kola (Heckel) seed extract on some pathogens. Afr. J. Biotechnol. 2008, 7, 3934-3938.
37. Boyanova, L.; Galina, G.; Rossen, N.; Sirigan, D.; Lazarova, E.; Katsarov, N.; Mitov, I.; Krastev, Z. Activity of Bulgarian propolis against 94 Helicobacter pylori strains in vitro by agar-well diffusion, agar dilution and disc diffusion methods. J. Med. Microbiol. 2005, 54, 481-483.
38. Bonacorsi, C.; Raddi, M.S.G.; Iracilda, Z.C.; Sannomiya, M.; Vilegas, W. Anti-Helicobacter pylori activity and immunostimulatory effect of extracts from Byrsonima crassa Nied. (Malpighiaceae). BMC Complement. Altern. Med. 2009, 9, 1472-6882.